Member access

4-Traders Homepage  >  News

News

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesHot NewsMost Read NewsRecomm.Business LeadersVideosCalendar 

Johnson & Johnson Innovation Announces Collaborations with Two Canadian Early-Stage Drug Technology Development Centers

12/10/2013 | 08:09am US/Eastern
Recommend:
0

Johnson & Johnson Innovation and its affiliate Janssen Inc. in Canada today announced new collaborations with two Canadian early-stage drug technology development centers, Montreal-based NEOMED and Toronto-based MaRS Innovation, to identify and advance promising bio/pharmaceutical technologies that have the potential to impact human health.

Through these collaborations, technical experts from the Johnson & Johnson Innovation Center in Boston, Massachusetts will work with NEOMED and MaRS Innovation to identify investment opportunities emerging from well-validated scientific research discoveries within their communities of academic institutions and biotechnology companies.

"We know from our history of engagement that the Canadian bio/pharmaceutical environment is one of the most vibrant in the world," said Robert Urban, Head of the Johnson & Johnson Innovation Center, Boston. "These new collaborations will allow us to potentially advance important new clinical candidates against disease."

"Quebec and Ontario are home to numerous world-class academic and biomedical research enterprises," said Paul Kershaw, Vice President of Medical Affairs, Janssen Inc. in Canada. "These new relationships with NEOMED and MaRS Innovation are an extension of our commitment to Canada's innovative research community."

NEOMED is a not-for-profit, public-private Pharma alliance dedicated to drug discovery and development. Partially funded by the Ministère des Finances et de l'Économie du Québec, NEOMED is within the NEOMED Institute, a state-of-the-art R&D facility in the Montréal Technoparc.

MaRS Innovation is the commercialization agent for Ontario's discovery pipeline from 16 leading academic institutions. MaRS Innovation is supported by the Government of Canada through the Networks of Centres of Excellence, by the Government of Ontario through the Ontario Centres of Excellence, and by its 16 member institutions.

About Johnson & Johnson Innovation

The Boston Innovation Center is part of Johnson & Johnson Innovation, a division of Johnson & Johnson Finance Corporation. Johnson & Johnson Innovation focuses on accelerating early innovation and enhancing opportunities for collaboration and investment across Johnson & Johnson's global healthcare businesses. Johnson & Johnson Innovation provides scientists, entrepreneurs and emerging companies focused on early-stage opportunities a one-stop access to science and technology experts who can facilitate collaborations across the pharmaceutical, medical device and diagnostics and consumer companies of Johnson & Johnson. Johnson & Johnson Innovation includes local deal-making capabilities with the flexibility to adapt deal structures to match early-stage opportunities and establish novel collaborations that speed development of those innovations to solve unmet needs in patients. Follow us @jnjinnovation on Twitter. Please visit www.jnjinnovation.com for more information.

About Janssen Inc.

Janssen is dedicated to addressing and solving some of the most important unmet medical needs of our time in oncology, immunology, neuroscience, infectious diseases and vaccines, metabolic and chronic diseases and women's health. Driven by our commitment to patients, we bring innovative products, services and solutions to people throughout the world. Janssen Inc. in Canada is part of the Janssen Pharmaceutical Companies of Johnson & Johnson. Please visit http://www.janssen.ca for more information.

Johnson & Johnson
John Lacey, 781-392-5514
jlacey1@ITS.JNJ.com
or
Feinstein Kean Healthcare
Jessica Rowlands, 202-729-4089
jessica.rowlands@fkhealth.com


© Business Wire 2013
Recommend :
0
React to this article
Latest news
Date Title
<1m ago NATIONAL OILWELL VARCO : Announces $3 Billion Share Repurchase Plan
1m ago MICROSOFT : Feds say hackers targeted Microsoft, game makers
1m ago Alternative investments often outperform equities in weaker markets - Davis
1m ago ERYTECH : Reports Positive Top-Line Phase III Results from Clinical Study with GRASPA® in Acute Lymphoblastic Leukemia
2m ago NEOPOST : 2014 Interim Financial Report Available
3m ago FEDERATED SAMPLE : Launches Fulcrum As Independent Division
3m ago Form 8.3 - Fyffes PLC
4m ago Hedge fund Third Point joined Icahn in pressuring eBay
4m ago CONTROL4 : Hayward(R) OmniLogic(R) to Be the First Certified Pool Controller Featuring Control4 SDDP for Control4(R) Home Automation Systems
4m ago AUSTIN FILM FESTIVAL : ’s Opening Night Selections to Include Richard LaGravenese Presenting The Last 5 Years and the US Premiere of The Humbling
Latest news
Advertisement
Hot News 
Bank derivatives boom ahead of ECB test results as investors play safe
News Corp to buy real estate website operator Move for $950 mln
CYAN : Executive Chairman role and grant of options
RAME ENERGY : Says Widened Loss Is "In Line With Expectations"
GULFSANDS PETROLEUM : First-Half Loss Narrows On Revenue Rise, Cost Reduction
Most Read News
12h ago QUINDELL : simply quizzical over its sliding shares
1d ago LENOVO : edges close to IBM server deal
1d ago SOFTBANK : DreamWorks Animation talks cool - WSJ
1d ago ALLERGAN : Valeant Pharmaceuticals' third-quarter sales to rise
1d ago BOEING : to shift most defense work out of Washington state
Most recommended articles
1m ago Alternative investments often outperform equities in weaker markets - Davis
4m ago Hedge fund Third Point joined Icahn in pressuring eBay
5m ago AIRBUS : A380 breakeven goal still stands - CEO tells Le Figaro
9m agoDJRussian Ruble Hits Record Low Against Target Currency Basket -- Update
10m agoDJU.K. Carries Out First Airstrikes in Iraq
Dynamic quotes  
ON
| OFF